Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

120.25 +2.16 (+1.82%)
Streaming Delayed Price Updated: 10:24 AM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,437,678
Open 119.03
Bid (Size) 120.21 (100)
Ask (Size) 120.30 (100)
Prev. Close 118.10
Today's Range 118.77 - 121.27
52wk Range 73.31 - 125.14
Shares Outstanding 2,531,374,696
Dividend Yield 2.83%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Biotech Defies Gravity: Sarepta and Corcept Lead Midday Healthcare Rally Amidst Market Volatility
In a trading session characterized by sharp declines across the technology and industrial sectors, the healthcare industry emerged as a resilient fortress on March 31, 2026. While the broader S&P 500... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
News headline image
Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability
As of March 31, 2026, Moderna Inc. (NASDAQ: MRNA) finds itself at a defining historical junction. After years of being defined by a single, world-altering product—its COVID-19 vaccine—the... 
Via Finterra
Topics Initial Public Offering

Performance

YTD
+13.0%
+13.0%
1 Month
-1.0%
-1.0%
3 Month
+12.8%
+12.8%
6 Month
+53.0%
+53.0%
1 Year
+34.0%
+34.0%

More News

Read More
Merck & Co. Inc. (NYSE:MRK) Offers a Steady Dividend Backed by Strong Fundamentals ↗
Via Chartmill
News headline image
Merck Just Made a Big Bet on a New Cancer Growth Engine ↗
Via MarketBeat
News headline image
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
From Merck & Co., Inc.
Via Business Wire
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Positive Data from Phase 2 CADENCE Trial Provides Definitive Proof-of-Concept for WINREVAIR™ (sotatercept-csrk) in Adults With the Syndrome of Combined Post- and Precapillary Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
From Merck & Co., Inc.
Via Business Wire
News headline image
1 Reason Eli Lilly Stock Is Still a Buy ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Healthcare Stocks That Could Soar Over the Next 5 Years ↗
Via The Motley Fool
News headline image
MarketMinute: Corcept Therapeutics (CORT) Surges 19.66% on Surprise FDA Approval and Oncology Breakthrough
Via MarketMinute
Topics Intellectual Property
ARM Makes Its Move While Wall Street Watches the Strait ↗
Via Chartmill
News headline image
The Strategic Renaissance: Why 2026 is the Year of the Takeover Tailwind
Via MarketMinute
Topics Artificial Intelligence Economy
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience
Via Finterra
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
From Terns Pharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Merck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
From Merck & Co., Inc.
Via Business Wire
News headline image
1 S&P 500 Stock to Target This Week and 2 We Ignore
Via StockStory
Topics Stocks
News headline image
Bristol-Myers Squibb Shares Jump 3.3% on Robust 2026 Guidance and High Dividend Yield
Via MarketMinute
Topics Economy Initial Public Offering Intellectual Property
News headline image
Pfizer vs Moderna: Which Pharma Stock Has More Upside? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
From Merck & Co., Inc.
Via Business Wire
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
The Grand Divergence: Finance Surges as Health Care Braces for a Historic Q1 Earnings Slump
Via MarketMinute
Topics Earnings Economy Initial Public Offering
News headline image
Merck to Present New Data Reinforcing Long-Term Efficacy of GARDASIL®9 and GARDASIL® at the EUROGIN International Multidisciplinary HPV Congress 2026
From Merck Sharp & Dohme
Via Business Wire
News headline image
The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery
Via MarketMinute
Topics Artificial Intelligence Initial Public Offering Stocks
News headline image
Merck & Co. Trades Ex-Dividend as Healthcare Emerges as a Volatility Hedge in 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 120.25
When was Merck & Co last traded?
The last trade of Merck & Co was at 03/31/26 10:24 AM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 304.41B
How many shares of Merck & Co are outstanding?
Merck & Co has 304B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.